Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.
Criminal justice
Opioid-related disorders
Pharmacotherapy
Veterans
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
19
09
2020
revised:
07
12
2020
accepted:
28
02
2021
pubmed:
4
6
2021
medline:
14
9
2021
entrez:
3
6
2021
Statut:
ppublish
Résumé
Veterans involved in the legal system have a high risk of overdose mortality but limited utilization of medications for opioid use disorder (MOUD). To increase the use of MOUD in Veterans Health Administration (VHA) facilities and reduce overdose mortality, the VHA should incorporate strategies identified by legal-involved veterans to improve quality of care and ensure that their patients' experiences are integrated into care delivery. This study aims to determine strategies to increase use of MOUD from the perspective of legal-involved veterans with a history of opioid use or opioid use disorder (OUD). Between February 2018 and March 2019, we conducted semistructured interviews with 18 veterans with a history of opioid use or OUD and legal involvement (15 men and 3 women; mean age 41, standard deviation 13, range 28-61). Veterans were from 9 geographically dispersed United States VHA facilities. The study analyzed verbatim transcripts using the framework method. The primary focus was themes that represented legal-involved veteran-identified strategies to improve the use of MOUD. The 18 veterans interviewed had legal involvement directly related to their opioid use and most (n = 15; 83%) had previously used MOUD. Veteran-identified strategies to improve access to and use of MOUD included: (1) VHA should provide transportation or telehealth services; (2) legal agencies should increase access to MOUD during incarceration; (3) the VHA should reduce physician turnover; (4) the VHA should improve physician education to deliver compassionate, patient-centered treatment; (5) the VHA should improve veteran education about MOUD; and (6) the VHA should provide social support opportunities to veterans. Legal-involved veterans provided strategies that can inform and expand MOUD to better meet their needs and the treatment needs of all patients with OUD. The VHA should consider incorporating these strategies into care, and should evaluate their impact on patients' experience, initiation of and retention on medications, and overdose rates.
Sections du résumé
BACKGROUND
Veterans involved in the legal system have a high risk of overdose mortality but limited utilization of medications for opioid use disorder (MOUD). To increase the use of MOUD in Veterans Health Administration (VHA) facilities and reduce overdose mortality, the VHA should incorporate strategies identified by legal-involved veterans to improve quality of care and ensure that their patients' experiences are integrated into care delivery. This study aims to determine strategies to increase use of MOUD from the perspective of legal-involved veterans with a history of opioid use or opioid use disorder (OUD).
METHODS
Between February 2018 and March 2019, we conducted semistructured interviews with 18 veterans with a history of opioid use or OUD and legal involvement (15 men and 3 women; mean age 41, standard deviation 13, range 28-61). Veterans were from 9 geographically dispersed United States VHA facilities. The study analyzed verbatim transcripts using the framework method. The primary focus was themes that represented legal-involved veteran-identified strategies to improve the use of MOUD.
RESULTS
The 18 veterans interviewed had legal involvement directly related to their opioid use and most (n = 15; 83%) had previously used MOUD. Veteran-identified strategies to improve access to and use of MOUD included: (1) VHA should provide transportation or telehealth services; (2) legal agencies should increase access to MOUD during incarceration; (3) the VHA should reduce physician turnover; (4) the VHA should improve physician education to deliver compassionate, patient-centered treatment; (5) the VHA should improve veteran education about MOUD; and (6) the VHA should provide social support opportunities to veterans.
CONCLUSIONS
Legal-involved veterans provided strategies that can inform and expand MOUD to better meet their needs and the treatment needs of all patients with OUD. The VHA should consider incorporating these strategies into care, and should evaluate their impact on patients' experience, initiation of and retention on medications, and overdose rates.
Identifiants
pubmed: 34080564
pii: S0740-5472(21)00079-9
doi: 10.1016/j.jsat.2021.108353
pmc: PMC8380634
mid: NIHMS1680046
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
108353Subventions
Organisme : HSRD VA
ID : RCS 00-001
Pays : United States
Organisme : HSRD VA
ID : RCS 14-232
Pays : United States
Organisme : NIDA NIH HHS
ID : R21 DA041489
Pays : United States
Organisme : HSRD VA
ID : IK2 HX001513
Pays : United States
Organisme : HSRD VA
ID : IK6 HX002840
Pays : United States
Organisme : Intramural VA
ID : RCS 00-001
Pays : United States
Organisme : HSRD VA
ID : CDA 13-279
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
Addiction. 2018 Apr;113(4):656-667
pubmed: 28987068
Drug Alcohol Depend. 2016 Mar 1;160:112-8
pubmed: 26796596
J Stud Alcohol Drugs. 2018 Nov;79(6):909-917
pubmed: 30573022
Addict Sci Clin Pract. 2016 Sep 15;11(1):15
pubmed: 27633982
J Subst Abuse Treat. 2020 Apr;111:54-66
pubmed: 32076361
Adm Policy Ment Health. 2017 Mar;44(2):177-187
pubmed: 26687114
Med Care. 2020 Apr;58(4):384-391
pubmed: 31985588
Addict Sci Clin Pract. 2019 Mar 13;14(1):11
pubmed: 30867068
Harm Reduct J. 2020 Nov 17;17(1):88
pubmed: 33203460
Subst Abus. 2018;39(2):139-144
pubmed: 29595375
Addict Sci Clin Pract. 2015 Jan 16;10:2
pubmed: 25592182
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
PLoS One. 2016 Jan 05;11(1):e0145817
pubmed: 26731679
J Health Soc Behav. 2007 Jun;48(2):115-30
pubmed: 17583269
J Addict Med. 2020 Jul/Aug;14(4):e44-e52
pubmed: 31651562
Psychiatr Serv. 2014 Jul;65(7):853-61
pubmed: 24838535
J Subst Abuse Treat. 2013 May-Jun;44(5):502-5
pubmed: 23433809
J Subst Abuse Treat. 2013 Nov-Dec;45(5):475-7
pubmed: 23932227
Health Care Manage Rev. 2003 Apr-Jun;28(2):119-39
pubmed: 12744449
J Gen Intern Med. 2020 Sep;35(9):2529-2536
pubmed: 32583337
Int J Drug Policy. 2020 Jul;81:102768
pubmed: 32446130
J Subst Abuse Treat. 2019 Apr;99:32-43
pubmed: 30797392
J Subst Abuse Treat. 2019 Sep;104:104-115
pubmed: 31370974
J Subst Abuse Treat. 2019 Sep;104:28-33
pubmed: 31370982
Int J Drug Policy. 2021 May;91:102841
pubmed: 32712165
Addiction. 2019 Aug;114(8):1396-1404
pubmed: 30916463
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Am J Addict. 2020 Nov;29(6):485-491
pubmed: 32367557
J Subst Abuse Treat. 2015 Mar;50:50-8
pubmed: 25456091
J Am Med Inform Assoc. 2016 May;23(3):491-5
pubmed: 26911810
Subst Abus. 2018;39(4):404-409
pubmed: 29432086
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):76-89
pubmed: 25747921
J Addict Med. 2020 Jul/Aug;14(4):e136-e138
pubmed: 32433364
J Gen Intern Med. 2020 Sep;35(9):2833
pubmed: 32578016
J Gen Intern Med. 2020 Dec;35(Suppl 3):954-963
pubmed: 33145687
J Subst Abuse Treat. 2018 Dec;95:43-47
pubmed: 30352669
Prev Chronic Dis. 2016 Mar 31;13:E44
pubmed: 27032987
Addict Sci Clin Pract. 2019 Oct 1;14(1):37
pubmed: 31570100
J Subst Abuse Treat. 2014 Apr;46(4):511-5
pubmed: 24468235
Qual Health Res. 2017 Mar;27(4):591-608
pubmed: 27670770
Subst Abus. 2020;41(3):275-282
pubmed: 32697170
J Rural Health. 2019 Jan;35(1):108-112
pubmed: 29923637
Med Care. 2018 Dec;56(12):1009-1017
pubmed: 30383571
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
Ann Intern Med. 2018 Aug 7;169(3):137-145
pubmed: 29913516
J Subst Abuse Treat. 2021 Mar;122:108196
pubmed: 33221125
J Am Pharm Assoc (2003). 2020 Jul - Aug;60(4):e31-e42
pubmed: 32253087
J Addict Med. 2021 Apr 1;15(2):143-149
pubmed: 32826617
J Am Acad Psychiatry Law. 2012;40(3):348-54
pubmed: 22960917
JAMA Intern Med. 2014 Dec;174(12):1947-54
pubmed: 25330017
Am Fam Physician. 2015 Jul 15;92(2):118-24
pubmed: 26176370
Subst Abus. 2020 Feb 20;:1-8
pubmed: 32078492
Arthrosc Sports Med Rehabil. 2019 Dec 20;2(1):e33-e38
pubmed: 32266356
Subst Use Misuse. 2019;54(14):2409-2419
pubmed: 31429351
Addict Sci Clin Pract. 2019 Aug 26;14(1):34
pubmed: 31446893
J Subst Abuse Treat. 2016 Apr;63:1-9
pubmed: 26882891
Curr Psychiatry Rep. 2011 Oct;13(5):374-81
pubmed: 21773951
J Subst Abuse Treat. 2015 Jan;48(1):112-6
pubmed: 25205666
Ann Intern Med. 2013 Nov 5;159(9):592-600
pubmed: 24189594